$ETST Dr. Michel Aube, ETST’s CEO & CSO opines, “we have selected the research center that will conduct the in vitro assays to demonstrate the efficiency of the nutraceuticals in the ETST product pipeline which are based on the company’s International Provisory Patent Application.”
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!